お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
974562

チェックポイント阻害剤の世界市場 (2020-2030年) :COVID-19による成長と変化

Checkpoint Inhibitors Global Market Report 2020-30: COVID-19 Growth and Change

出版日: 受注後作成 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2~10営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.75円
チェックポイント阻害剤の世界市場 (2020-2030年) :COVID-19による成長と変化
出版日: 受注後作成
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界のチェックポイント阻害剤市場について調査分析し、市場概要、市場規模と予測、セグメント別の市場分析、地域・国別の市場分析、競合情勢などについて、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 チェックポイント阻害剤市場の特徴

第3章 チェックポイント阻害剤の市場規模・成長率

  • 世界市場の実績 (金額ベース)
    • 市場の促進要因
    • 市場の抑制要因
  • 世界市場の予測 (金額ベース)
    • 市場の促進要因
    • 市場の抑制要因

第4章 チェックポイント阻害剤市場のセグメンテーション

  • 世界市場のセグメンテーション:薬剤別、実績と予測 (金額ベース)
    • PD-1阻害剤
    • PD-L1阻害剤
    • CTLA-4
    • キメラ抗原受容体T細胞
    • その他
  • 世界市場のセグメンテーション:アプリケーション別、実績と予測 (金額ベース)
    • 肺がん
    • 腎がん
    • 血液がん
    • 膀胱がん
    • 黒色腫
    • その他

第5章 チェックポイント阻害剤市場:地域・国別の分析

  • 世界市場の区分:地域別、実績と予測 (金額ベース)
  • 世界市場の区分:国別、実績と予測 (金額ベース)

第6章 アジア太平洋のチェックポイント阻害剤市場

  • 市場概要
  • 市場セグメンテーション:薬剤別、実績と予測 (金額ベース)
  • 市場セグメンテーション:アプリケーション別、実績と予測 (金額ベース)

第7章 中国のチェックポイント阻害剤市場

第8章 インドのチェックポイント阻害剤市場

第9章 日本のチェックポイント阻害剤市場

第10章 オーストラリアのチェックポイント阻害剤市場

第11章 インドネシアのチェックポイント阻害剤市場

第12章 韓国のチェックポイント阻害剤市場

第13章 西欧のチェックポイント阻害剤市場

第14章 英国のチェックポイント阻害剤市場

第15章 ドイツのチェックポイント阻害剤市場

第16章 フランスのチェックポイント阻害剤市場

第17章 東欧のチェックポイント阻害剤市場

第18章 ロシアのチェックポイント阻害剤市場

第19章 北米のチェックポイント阻害剤市場

第20章 米国のチェックポイント阻害剤市場

第21章 南米のチェックポイント阻害剤市場

第22章 ブラジルのチェックポイント阻害剤市場

第23章 中東のチェックポイント阻害剤市場

第24章 アフリカのチェックポイント阻害剤市場

第25章 市場の競合情勢と企業プロファイル

  • 競合情勢
  • 企業プロファイル
    • AstraZeneca PLC
    • Bristol-Myers Squibb Company
    • Merck & Co., Inc.
    • Roche Holding AG
    • Pfizer

第26章 主要なM&A

第27章 市場動向と戦略

第28章 将来展望と潜在性分析

第29章 付録

目次

“Checkpoint Inhibitors Global Market Report 2020-30: COVID-19 Growth And Change” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global checkpoint inhibitors market market.

This report focuses on checkpoint inhibitors market market which is experiencing strong growth. The report gives a guide to the checkpoint inhibitors market market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the checkpoint inhibitors market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Checkpoint Inhibitors Market market global report ”from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider checkpoint inhibitors market market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the Covid 19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The checkpoint inhibitors market market section of the report gives context. It compares the checkpoint inhibitors market market with other segments of the checkpoint inhibitors market market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, checkpoint inhibitors market indicators comparison.

Scope

Markets Covered:

  • 1) By Drug: PD-1 Inhibitors; PD-L1 Inhibitors; CTLA-4; Chimeric Antigen Receptor T-cell; Others
  • 2) By Application: Lung Cancer; Renal Cancer; Blood Cancer; Bladder Cancer; Melanoma; Others
  • Companies Mentioned: AstraZeneca PLC; Bristol-Myers Squibb Company; Merck & Co., Inc.; Roche Holding AG; Pfizer
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series:: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations:: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Checkpoint Inhibitors Market Characteristics

3. Checkpoint Inhibitors Market Size And Growth

  • 3.1. Global Checkpoint Inhibitors Historic Market, 2015 - 2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Checkpoint Inhibitors Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Checkpoint Inhibitors Market Segmentation

  • 4.1. Global Checkpoint Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • PD-1 Inhibitors
  • PD-L1 Inhibitors
  • CTLA-4
  • Chimeric Antigen Receptor T-cell
  • Others
  • 4.2. Global Checkpoint Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Lung Cancer
  • Renal Cancer
  • Blood Cancer
  • Bladder Cancer
  • Melanoma
  • Others

5. Checkpoint Inhibitors Market Regional And Country Analysis

  • 5.1. Global Checkpoint Inhibitors Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 5.2. Global Checkpoint Inhibitors Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Checkpoint Inhibitors Market

  • 6.1. Asia-Pacific Checkpoint Inhibitors Market Overview
  • 6.2. Asia-Pacific Checkpoint Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 6.3. Asia-Pacific Checkpoint Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Checkpoint Inhibitors Market

  • 7.1. China Checkpoint Inhibitors Market Overview
  • 7.2. China Checkpoint Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
  • 7.3. China Checkpoint Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Checkpoint Inhibitors Market

  • 8.1. India Checkpoint Inhibitors Market Overview
  • 8.2. India Checkpoint Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 8.3. India Checkpoint Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Checkpoint Inhibitors Market

  • 9.1. Japan Checkpoint Inhibitors Market Overview
  • 9.2. Japan Checkpoint Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 9.3. Japan Checkpoint Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Checkpoint Inhibitors Market

  • 10.1. Australia Checkpoint Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 10.2. Australia Checkpoint Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Checkpoint Inhibitors Market

  • 11.1. Indonesia Checkpoint Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 11.2. Indonesia Checkpoint Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Checkpoint Inhibitors Market

  • 12.1. South Korea Checkpoint Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 12.2. South Korea Checkpoint Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Checkpoint Inhibitors Market

  • 13.1. Western Europe Checkpoint Inhibitors Market Overview
  • 13.2. Western Europe Checkpoint Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 13.3. Western Europe Checkpoint Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Checkpoint Inhibitors Market

  • 14.1. UK Checkpoint Inhibitors Market Overview
  • 14.2. UK Checkpoint Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 14.3. UK Checkpoint Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Checkpoint Inhibitors Market

  • 15.1. Germany Checkpoint Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 15.2. Germany Checkpoint Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Checkpoint Inhibitors Market

  • 16.4. France Checkpoint Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 16.5. France Checkpoint Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Checkpoint Inhibitors Market

  • 17.1. Eastern Europe Checkpoint Inhibitors Market Overview
  • 17.2. Eastern Europe Checkpoint Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 17.3. Eastern Europe Checkpoint Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Checkpoint Inhibitors Market

  • 18.1. Russia Checkpoint Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 18.2. Russia Checkpoint Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Checkpoint Inhibitors Market

  • 19.1. North America Checkpoint Inhibitors Market Overview
  • 19.2. North America Checkpoint Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 19.3. North America Checkpoint Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Checkpoint Inhibitors Market

  • 20.1. USA Checkpoint Inhibitors Market Overview
  • 20.2. USA Checkpoint Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 20.3. USA Checkpoint Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Checkpoint Inhibitors Market

  • 21.1. South America Checkpoint Inhibitors Market Overview
  • 21.2. South America Checkpoint Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 21.3. South America Checkpoint Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Checkpoint Inhibitors Market

  • 22.1. Brazil Checkpoint Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 22.2. Brazil Checkpoint Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Checkpoint Inhibitors Market

  • 23.1. Middle East Checkpoint Inhibitors Market Overview
  • 23.2. Middle East Checkpoint Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 23.3. Middle East Checkpoint Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Checkpoint Inhibitors Market

  • 24.1. Africa Checkpoint Inhibitors Market Overview
  • 24.2. Africa Checkpoint Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 24.3. Africa Checkpoint Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Checkpoint Inhibitors Market Competitive Landscape And Company Profiles

  • 25.1. Checkpoint Inhibitors Market Competitive Landscape
  • 25.2. Checkpoint Inhibitors Market Company Profiles
    • 25.2.1. AstraZeneca PLC
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. Bristol-Myers Squibb Company
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. Merck & Co., Inc.
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Roche Holding AG
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. Pfizer
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Checkpoint Inhibitors Market

27. Checkpoint Inhibitors Market Trends And Strategies

28. Checkpoint Inhibitors Market Future Outlook and Potential Analysis

29. Appendix

  • 29.1. Abbreviations
  • 29.2. Currencies
  • 29.3. Research Inquiries
  • 29.4. The Business Research Company
  • 29.5. Copyright And Disclaimer
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.